N-((tetrahydrofuran-2-yl)methyl)-6-(trifluoromethoxy)benzo[d]thiazol-2-amine, 95.0%, 250mg

2-(chloromethyl)-3-methylquinoxaline, 95.0%, 250mg

4-Amino-1-[3,5-bis-O-(4-chlorobenzoyl)-2-deoxy-D-erythro-pentofuranosyl]-1,3,5-triazin-2(1H)-one, 98%, 250mg

N-(5-(p-Tolyl)-1,3,4-thiadiazol-2-yl)benzamide, 95%, 25mg

Flat flange reaction vial, cylindrical, graduated, with tempering jacket GL connecting piece, DN 150, 4000 ml, 190 mm, 1 Piece

1-Iminothiomorpholine 1-oxide hydrochloride, 95%, 1g

2-Amino-3-iodobenzoic acid, 95.0%, 25g

5,5'-Dimethyl-2,2'-bipyridyl>98.0%(GC)(T)5g

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-methylhexanoic acid, 95.0%, 10g

2-(Naphthalen-2-yl)acetonitrile, 97.0%, 100g

4-AMINOBICYCLO[2.2.1]HEPTAN-1-OL HCL, 95.0%, 1g

3-Bromo-2-fluorobenzaldehyde, 97.0%, 5g

tert-butyl 4-amino-4-(trifluoromethyl)piperidine-1-carboxylate, 95.0%, 25g